Financial Performance - The company's revenue for Q3 2024 reached ¥1,012,813,634.81, an increase of 8.11% compared to the same period last year[2] - Net profit attributable to shareholders was ¥151,797,097.62, reflecting a growth of 24.51% year-over-year[2] - The net profit after deducting non-recurring gains and losses was ¥145,543,919.08, up by 21.10% from the previous year[2] - Total operating revenue for Q3 2024 reached CNY 2,966,224,206.50, an increase of 6.4% compared to CNY 2,787,191,999.36 in the same period last year[13] - Operating profit for the period was CNY 613,744,020.83, up from CNY 543,056,470.75, reflecting a growth of 12.9%[14] - Net profit attributable to shareholders of the parent company was CNY 482,234,096.93, compared to CNY 440,863,203.20 in the previous year, marking an increase of 9.4%[15] - The company reported a total comprehensive income of CNY 530,503,925.11, compared to CNY 485,347,872.65 in the previous year, an increase of 9.3%[15] - The total operating costs for the period were CNY 2,398,011,921.85, up from CNY 2,253,523,750.66, reflecting an increase of 6.4%[13] Assets and Liabilities - The total assets at the end of the reporting period amounted to ¥9,219,558,802.72, representing a 5.01% increase from the end of the previous year[2] - The total liabilities of the company are not explicitly stated, but short-term borrowings increased to CNY 309.89 million from CNY 282.91 million, an increase of about 9.5%[10] - Total liabilities increased to CNY 2,142,050,216.50 from CNY 1,993,326,770.74, representing a growth of 7.5%[12] - The company's total equity reached CNY 7,077,508,586.22, up from CNY 6,786,310,112.54, reflecting an increase of 4.3%[12] Cash Flow - The cash flow from operating activities for the year-to-date was ¥357,107,272.30, showing a 13.54% increase year-over-year[2] - Operating cash inflow for the period reached CNY 2,348,012,935.00, an increase from CNY 2,304,095,211.72 in the previous period[17] - Net cash flow from operating activities was CNY 357,107,272.30, compared to CNY 314,511,797.19 in the same period last year, reflecting a growth of approximately 13.5%[17] - Cash outflow from investing activities totaled CNY 397,724,564.57, a decrease from CNY 610,935,748.48 in the previous period[18] - Net cash flow from financing activities was negative at CNY -160,755,492.21, contrasting with a positive CNY 316,202,632.02 in the prior year[18] - The company reported a net decrease in cash and cash equivalents of CNY -95,011,306.16, compared to an increase of CNY 56,914,556.27 in the previous period[18] - Cash and cash equivalents at the end of the period stood at CNY 480,049,347.03, down from CNY 561,856,296.58 at the end of the previous period[18] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 32,619[6] - The top shareholder, Zhang Xi, holds 20.34% of the shares, totaling 202,848,941 shares[6] Operational Metrics - The weighted average return on equity was 2.32%, an increase of 0.41% compared to the previous year[2] - Research and development expenses amounted to CNY 208,467,971.32, up from CNY 174,325,690.66, indicating a rise of 19.6% year-over-year[14] - The company reported a significant increase in accounts receivable financing by 76.60% due to an increase in bank notes received from customers[5] - Management expenses increased by 23.44% due to the consolidation of Dekema into the financial statements[5] - The company reported a significant increase in contract assets to CNY 4.88 million from CNY 2.74 million, reflecting a growth of approximately 78.3%[10] - The company's long-term equity investments increased to CNY 148.60 million from CNY 143.92 million, showing a growth of approximately 3.7%[10] - The company's long-term borrowings increased to CNY 360,540,850.40 from CNY 277,636,027.29, indicating a rise of 30%[12] Inventory and Current Assets - Current assets totaled CNY 3.84 billion, up from CNY 3.67 billion at the beginning of the period, indicating a growth of approximately 4.2%[10] - Inventory increased to CNY 917.05 million from CNY 789.47 million, reflecting a growth of about 16.2%[10] - Accounts receivable rose to CNY 1.75 billion, compared to CNY 1.66 billion at the beginning of the period, marking an increase of approximately 5.5%[10] - Cash and cash equivalents decreased to CNY 550.42 million from CNY 718.82 million, a decline of about 23.4%[9] Product Development and Market Strategy - The company has not disclosed any new product developments or market expansion strategies in the current report[9]

证券代码：300285 证券简称：国瓷材料 公告编号：2024-078 公司董事认真审阅了《公司2024年第三季度报告》，认为《公司2024年第三季度 报告》所载资料的内容符合法律、行政法规、中国证监会和深圳证券交易所的相关规 定，报告内容真实、准确、完整地反映了公司的实际情况，本议案已经公司董事会审 计委员会审议通过，公司的董事、监事和高级管理人员均对报告出具了书面确认意 见。《公司2024年第三季度报告》详见中国证监会指定的创业板信息披露网站巨潮资 讯网（http://www.cninfo.com.cn）。 表决结果：9票赞成，0票反对，0票弃权，获得通过。 二、审议通过了《关于追加2024年度日常关联交易预计额度的议案》 公司追加山东国瓷康立泰新材料科技有限公司与科达制造股份有限公司及其相关 方之间的日常关联交易预计额度，是基于公司的实际情况作出的决定，满足了下属子 公司的正常生产经营所需，未违反公开、公平、公正的原则，符合中国证监会、深圳 证券交易所和公司关于关联交易管理的有关法律法规及公司章程的规定，不存在损害 山东国瓷功能材料股份有限公司 第五届董事会第十八次会议决议公告 本公司及董事会全体成员保 ...

关于追加 2024 年度日常关联交易预计额度的公告 证券代码：300285 证券简称：国瓷材料 公告编号：2024-080 山东国瓷功能材料股份有限公司 一、日常关联交易基本情况 (一)关联交易概述 2023 年 7 月 5 日，公司召开第五届董事会第八次会议，审议通过了《关于 放弃优先购买权暨关联交易的议案》，公司控股子公司山东国瓷康立泰新材料科 技有限公司（以下简称"国瓷康立泰"）的少数股东佛山市康立泰无机化工有限 公司将其持有的 40%股权转让给科达制造股份有限公司（以下简称"科达制造"）， 本次交易事项完成后，公司对国瓷康立泰的持股比例不变，国瓷康立泰仍为公司 控股子公司。公司及控股子公司与科达制造及其相关方之间由于日常生产经营和 产品销售而产生的交易事项构成关联交易 本公司及董事会全体人员保证信息披露的内容真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 山东国瓷功能材料股份有限公司(以下简称"公司"或"国瓷材料")于 2024 年 10 月 27 日召开第五届董事会第十八次会议、第五届监事会第十八次会议，审议 通过了《关于追加 2024 年度日常关联交易预计额度的议案》。本次事项在公司 董 ...

证券代码：300285 证券简称：国瓷材料 公告编号：2024-079 山东国瓷功能材料股份有限公司 第五届监事会第十八次会议决议公告 本公司及监事会全体人员保证信息披露的内容真实、准确和完整，没有虚假记 载、误导性陈述或重大遗漏。 山东国瓷功能材料股份有限公司（以下简称"公司"或"国瓷材料"）于 2024 年 10 月 24 日以邮件形式发出了《第五届监事会第十八次会议的通知》。本次会议于 2024 年 10 月 27 日在公司会议室以现场会议和通讯会议的方式召开。会议应出席监事 3 名， 实际出席监事 3 名。本次会议的召集、召开符合《公司法》及《公司章程》的有关规 定，会议合法有效。本次会议由监事会主席温长云先生主持。 本次监事会对以下议案内容进行了表决，表决情况如下： 一、审议通过了《关于公司 2024 年第三季度报告的议案》 经审核，监事会认为：董事会编制和审核《公司2024年第三季度报告》的程序 符合法律、行政法规、中国证监会和深圳证券交易所的相关规定，报告内容真实、 准确、完整地反映了公司的实际情况，不存在任何虚假记载、误导性陈述或者重大 遗漏。 具 体 内 容 详 见 中 国 证 监 会 指 ...

Investment Rating - The investment rating for the company is "Outperform" with a target price of RMB 21.90, based on a 2024 PE of 30x [2][10]. Core Insights - In H1 2024, the company achieved a revenue of RMB 1.95 billion, representing a year-on-year growth of 5.57%, and a net profit attributable to shareholders of RMB 330 million, up 3.60% YoY [8][10]. - The company has six business sectors that are progressing well, including electronic materials, catalytic materials, biomedical materials, and precision ceramics, with notable growth in the catalytic materials sector [9][10]. - The company is focusing on domestic alternatives in the electronic materials sector and has successfully entered the supply chain of leading overseas commercial vehicle customers in the catalytic materials sector [9][10]. Financial Performance Summary - The company reported a revenue of RMB 3.859 billion in 2023, with projections of RMB 4.281 billion in 2024, RMB 4.889 billion in 2025, and RMB 5.666 billion in 2026, reflecting a year-on-year growth of 21.9% in 2023 and 10.9% in 2024 [3][6]. - The net profit for 2023 is projected at RMB 569 million, with forecasts of RMB 730 million in 2024, RMB 850 million in 2025, and RMB 997 million in 2026, indicating a net profit growth rate of 14.5% in 2023 and 28.3% in 2024 [3][6]. - The company’s gross margin is expected to improve from 38.7% in 2023 to 39.8% by 2026 [6][10]. Business Segment Analysis - The catalytic materials sector is projected to generate sales revenue of RMB 715.08 million in 2024, with a gross margin of 43% [4]. - The biomedical materials sector is expected to achieve sales revenue of RMB 854.68 million in 2024, with a gross margin of 59% [4]. - The electronic materials sector is forecasted to have sales revenue of RMB 598.49 million in 2024, with a gross margin of 36% [4].

证券代码：300285 证券简称：国瓷材料 公告编号：2024-075 截至本公告日，公司总股本 997,048,299 股，张曦先生股票累计质押情况如 下： 山东国瓷功能材料股份有限公司 关于公司第一大股东股权解除质押的公告 本公司及董事会全体成员保证公告内容真实、准确和完整，没有虚假记 载、误导性陈述或重大遗漏。 山东国瓷功能材料股份有限公司（以下简称"公司"或"国瓷材料"）于近日 收到公司第一大股东张曦先生的通知，获悉张曦先生将其持有的部分国瓷材料 股份办理了股份解除质押的相关业务。具体情况如下： 股东名称 是否为公司第 一大股东或实 际控制人 解除质押股数 （股） 占其所持股份 比例 占公司总股本 比例 质押开始日期 解除质押日期 质权人 张曦 是 7,580,000 3.737% 0.760% 2023.02.27 2024.10.15 招商证券股份有限公 司 张曦 是 50,000 0.025% 0.005% 2024.01.8 2024.10.15 招商证券股份有限公 司 张曦 是 120,000 0.059% 0.012% 2024.01.10 2024.10.15 招商证券股份有限公 司 张 ...

山东国瓷功能材料股份有限公司 关于继续回购公司股份的进展公告 本公司及董事会全体人员保证信息披露的内容真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 证券代码：300285 证券简称：国瓷材料 公告编号：2024-074 特此公告！ 山东国瓷功能材料股份有限公司 董事会 山东国瓷功能材料股份有限公司（以下简称"公司"）于2024年2月5日召开第五 届董事会第十三次会议和第五届监事会第十三次会议，审议并通过了《关于继续回 购公司股份方案的议案》，公司使用自有资金以集中竞价交易的方式回购部分公司 股份，用于股权激励计划或员工持股计划。本次回购的资金总额不低于人民币10,000 万元（含）且不超过人民币20,000万元（含），回购价格不超过人民币25元/股（含）。 回购股份的实施期限自董事会审议通过本次回购股份方案之日起不超过12个月。本 次回购股份事项在董事会审批权限内，无须提交股东大会审议。具体内容详见公司 于2024年2月6日在巨潮资讯网披露的相关公告。 一、股份回购进展情况 根据《深圳证券交易所上市公司自律监管指引第 9 号——回购股份》等相关 规定，上市公司应当在每个月的前三个交易日内披露截至上 ...

山东国瓷功能材料股份有限公司 简式权益变动报告书（王红） 上市公司名称：山东国瓷功能材料股份有限公司 股票上市地点：深圳证券交易所 股票简称：国瓷材料 股票代码：300285 信息披露义务人：王红 住所：山东省东营市东营区淮河路 通讯地址：山东省东营市东营区淮河路 股份变动性质：股份增加（协议转让） 签署日期：2024 年 9 月 27 日 三、依据《中华人民共和国证券法》《上市公司收购管理办法》的规定，本 报告书已全面披露了信息披露义务人在山东国瓷功能材料股份有限公司（以下简 称"国瓷材料"）中拥有权益的股份变动情况。 四、截至本报告书签署之日，除本报告书披露的信息外，上述信息披露义务 人没有通过任何其他方式增加或减少其在国瓷材料中拥有权益的股份。 五、本次权益变动是根据本报告所载明的资料进行的。信息披露义务人没有 委托或者授权任何其他人提供未在本报告书中列载的信息和对本报告书做出任 何解释或者说明。 六、信息披露义务人承诺本报告书不存在虚假记载、误导性陈述或重大遗漏， 并对其真实性、准确性、完整性承担个别和连带的法律责任。 2 | 第一节 | 释义 4 | | --- | --- | | 第二节 | 信息 ...

截至本公告日，公司总股本 997,048,299 股，张曦先生股票累计质押情况如 证券代码：300285 证券简称：国瓷材料 公告编号：2024-072 山东国瓷功能材料股份有限公司 关于公司第一大股东股权补充质押的公告 本公司及董事会全体成员保证公告内容真实、准确和完整，没有虚假记 载、误导性陈述或重大遗漏。 山东国瓷功能材料股份有限公司（以下简称"公司"或"国瓷材料"）于近日 收到公司第一大股东张曦先生的通知，获悉张曦先生将其持有的部分国瓷材料 股份办理了股份补充质押的相关业务。具体情况如下： | 股东名 称 | 是否为公司第 一大股东或实 | 本次质押数 量（股） | 占其所持 股份比例 | 占公司总股 本比例 | 是否为 限售股 | 是否为补 充质押 | | 质押开始日 质押到期日 | 质权人 | 用途 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | 际控制人 | | | | | | | | | | | 张曦 | 是 | 850,000 | 0.419% | 0.085% | 是 | 是 | 2024. ...

Investment Rating - The report maintains a "Buy" rating for Guoci Materials [1][3] Core Views - Guoci Materials is a leading manufacturer of high-end functional ceramic materials in China, with a diversified platform across six major business segments, including electronic materials, catalytic materials, biomedical materials, new energy materials, precision ceramics, and other materials [3][9] - The company has shown continuous revenue growth, with a compound annual growth rate (CAGR) of 31.30% from 2011 to 2023, and a net profit CAGR of 23.76% during the same period [3][23] - The report highlights the company's strong innovation capabilities and strategic acquisitions, positioning it well for future growth in the high-end ceramic materials market [3][9] Summary by Sections Business Overview - Guoci Materials has established a comprehensive industrial layout in the high-end ceramic materials sector over the past 20 years, with operations in various regions including North China, Northeast China, and Southeast Asia [9][21] - The company has developed a robust product portfolio that serves multiple industries, including electronics, automotive, and biomedical sectors [9][3] Financial Performance - The company's revenue reached 3,859 million yuan in 2023, with a year-on-year growth of 22% [1] - Net profit for 2023 was reported at 569 million yuan, reflecting a 15% increase compared to the previous year [1] - The report projects net profits of 734 million yuan in 2024, 932 million yuan in 2025, and 1,147 million yuan in 2026, indicating strong growth potential [1][3] Market Position and Competitive Advantage - Guoci Materials is recognized for its advanced technology and strong R&D capabilities, which have enabled it to penetrate the domestic new materials market effectively [3][9] - The company has a significant market share in the ceramic substrate and precision ceramic sectors, with expectations of rapid growth driven by increasing demand in the automotive and electronics industries [3][9] Future Outlook - The report anticipates that the company's strategic focus on high-end ceramic materials and its ongoing expansion into international markets will enhance its competitive position [3][9] - The potential for growth in the biomedical materials segment is particularly highlighted, with the domestic dental implant market expected to reach a scale of 100 billion yuan [3][9]